Coste-efectividad de la vacunación contra la varicela en adolescentes en España
Tài liệu tham khảo
Chin, 2000, Chickenpox/herpes. En: Control communicable diseases manual. 17th ed, 92
Gershon, 1999, Varicella vaccine, 475
Goldman, 2003, Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage, Vaccine, 21, 4243, 10.1016/S0264-410X(03)00459-6
Opstelten, 2002, Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database, Family Practice, 19, 471, 10.1093/fampra/19.5.471
Takahashi, 1974, Live vaccine to prevent the spread of varicella in children in hospital, Lancet, 2, 1288, 10.1016/S0140-6736(74)90144-5
Vázquez, 2001, The effectiveness of the varicella vaccine in clinical practice, N Engl J Med, 344, 955, 10.1056/NEJM200103293441302
Galil, 2002, Outbreak of varicella at a day-care center despite vaccination, N Engl J Med, 347, 1909, 10.1056/NEJMoa021662
2002, are two doses better than one? [editorial], N Engl J Med, 347, 1962, 10.1056/NEJMe020138
Thomas, 2000, Contacts with varicella or with children and protection against herpes zoster in adults: a casecontrol study, Lancet, 360, 678, 10.1016/S0140-6736(02)09837-9
Brisson, 2002, Exposure to varicella boots. Inmunity to herpes-zoster: implications for mass vaccination against chickenpox, Vaccine, 20, 2500, 10.1016/S0264-410X(02)00180-9
Brisson, 2000, Modelling the impact of immunization of the epidemiology of varicella zoster virus, Epidemiol Infect, 125, 651, 10.1017/S0950268800004714
Varilrix. Ficha técnica. Agencia Española del Medicamento, 2003 Disponible en: http://sinaem.agemed.es:83/presentación/ principal.asp.
Díez-Domingo, 2001, Epidemiología y coste de la varicela en niños atendidos en centros de salud en España, Vacunas, 2, 16
Forcén, 2000, Evaluación económica de la vacunación rutinaria a niños de 15 meses de edad frente al virus de la varicelazoster, An Sist Sanit Navar, 23, 115
Alonso, 1999, Vacuna antivaricela: ¿llegó el momento de su inclusión en el calendario vacunal español?, Bol Pediatr, 39, 229
Díez-Domingo, 1999, A cost benefit analysis of routine varicella vaccination in Spain, Vaccine, 1306, 10.1016/S0264-410X(98)00394-6
Drumond, 1991, Métodos para la evaluación económica de los programas de atención a la salud
2000, Estudio seroepidemiológico: situación de las enfermedades vacunables en España
Brisson, 2001, Epidemiology of varicella and zoster in Canada and the United Kingdom, Epidemiol Infect, 127, 305, 10.1017/S0950268801005921
Brisson, 2002, The cost-effectiveness of varicela vaccination in Canada, Vaccine, 20, 1113, 10.1016/S0264-410X(01)00437-6
1995, Madrid: Dirección General de Prevención y Promoción de la Salud, Consejería de Sanidad y Servicios Sociales
Rosner, 1995, Fundamentals of biostatistics. 4th ed.
Thiry, 2003, Van Doorslaer. Economic evaluation of varicella vaccination programmes. A review of the literature, Pharmacoecomomics, 21, 13, 10.2165/00019053-200321010-00002
Fleming, 2001, The incidence of chickenpox in the community, Eur J Epidemiol, 17, 1023, 10.1023/A:1020066806544
Gray, 1997, An economic analysis of varicella vaccination for health care workers, Epidemiol Infect, 119, 209, 10.1017/S0950268897007887